Operating income decreased 33.5%
Operating income changed -33.5% from the comparable as-filed period.
-$5.5M→-$7.3M2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →MEDS financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow decreased 39.2%
Operating cash flow changed -39.2% from the comparable as-filed period.
-$2.1M→-$2.9M3 prior comparisons
Operating margin moved 34208 bp lower
Operating margin changed -34208 basis points from the comparable as-filed period.
-70.60%→-412.68%1 prior comparisons
Cash & equivalents increased 484.9%
Cash & equivalents changed +484.9% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$419,942→$2.5M3 prior comparisons
Shares outstanding decreased 96.4%
Shares outstanding changed -96.4% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
84,064,100→3,061,9193 prior comparisons
Revenue decreased 77.2%
Revenue changed -77.2% from the comparable as-filed period.
$7.8M→$1.8M1 prior comparisons
Gross margin moved 375 bp higher
Gross margin changed +375 basis points from the comparable as-filed period.
6.49%→10.24%1 prior comparisons
Total assets decreased 39.6%
Total assets changed -39.6% from the comparable as-filed period.
$54.2M→$32.8M3 prior comparisons
Current assets decreased 58.3%
Current assets changed -58.3% from the comparable as-filed period.
$13.5M→$5.6M3 prior comparisons
Gross debt increased 36.6%
Gross debt changed +36.6% from the comparable as-filed period.
$23.3M→$31.8M2 prior comparisons
Inventory decreased 83.3%
Inventory changed -83.3% from the comparable as-filed period.
$9.0M→$1.5M2 prior comparisons
Reported total debt increased 36.6%
Reported total debt changed +36.6% from the comparable as-filed period.
$23.3M→$31.8M2 prior comparisons
Net debt increased 28.4%
Net debt changed +28.4% from the comparable as-filed period.
$22.9M→$29.3M2 prior comparisons
Gross profit decreased 64.0%
Gross profit changed -64.0% from the comparable as-filed period.
$505,752→$182,2041 prior comparisons
Stock-based compensation increased 28.8%
Stock-based compensation changed +28.8% from the comparable as-filed period.
$935,222→$1.2M1 prior comparisons
Inventory / revenue moved 3107 bp lower
Inventory / revenue changed -3107 basis points from the comparable as-filed period.
115.92%→84.85%1 prior comparisons
Cost of revenue decreased 78.1%
Cost of revenue changed -78.1% from the comparable as-filed period.
$7.3M→$1.6M1 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.